Big Gain For La Jolla Pharmaceutical Company
Thu, Jan 09, 2020 at 05:30 PM
La Jolla Pharmaceutical Company (LJPC:NASDAQ) jumped higher at $5.25, a gain of 35%. The stock appeared on our News Catalysts scanner on Thu 09 Jan 20 at 09:18 AM in the 'BIOTECH' category. From Tue 17 Dec 19, the stock recorded 42.86% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About La Jolla Pharmaceutical Company (LJPC:NASDAQ)
La Jolla Pharmaceutical Co is an American biopharmaceutical company. It is focused on the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases.
Top 10 Gainers:
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 122.84%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 93.96%
- Genetic Technologies Limited (GENE:NASDAQ), 45.09%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 36.53%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 35.71%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 34.96%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 34.71%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 33.59%
- KemPharm, Inc. (KMPH:NASDAQ), 31.72%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%